Over 300 Colorado Auctions End Today - Bid Now
Over 150 Total Lots Up For Auction at Two Locations - PA 05/15, NY 05/20

Gayrettepe Florence Nightingale Hospital in Instanbul to install RayPilot for hypofractionated prostate treatment

Press releases may be edited for formatting or style | January 11, 2016
7 January 2016 – Micropos has signed an agreement with the Turkish hospital Gayrettepe Florence Nightingale Hospital in Istanbul. The hospital will in early 2016 be the first Turkish clinic to start using RayPilot® real-time tracking system for extreme hypofractionated radiotherapy of prostate cancer patients.

This autumn, Gayrettepe Florence Nightingale visited Micropos' reference site, the Helsinki University Hospital in Finland, to learn how they use RayPilot to both streamline the prostate cancer treatment by hypofractionation and to reduce radiation to healthy surrounding tissue by the increased precision. Now Gayrettepe Florence Nightingale will start using the system with intention to increase productivity eightfold, by going from 40 to only 5 treatment sessions.

The agreement is enforced in cooperation with the Turkish distributor Oncotech and provides the opportunity for both Micropos and distributor to use the clinic as a reference for study trips and education of new customers.
stats
DOTmed text ad

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

stats
– We are very happy about this breakthrough in Turkey, where only Istanbul with about 14 millions inhabitants represent a great potential. Turkey has a large patient base treated on a combination of both public and private hospitals. This clinic has private international patients who travels far and they will now be able to offer them a treatment with great precision in only one eighth of the normal treatment time. There could also be a competitive advantage for the Gayrettepe Florence Nightingale in their effort to attract more patients. We once again see that interest in shortening the treatment time is now spreading around the world and the insight is that this cannot be achieved safely without high precision, which RayPilot ensures, says Micropos CEO, Tomas Gustafsson.

– In this era of hypofractionation on radiotherapy, it is extremely important to continuously treat our patients with highest precision capability and that's where we think RayPilot stands. We are delighted to announce an cooperation between Gayrettepe Florence Nightingale Hospital and Micropos team that will certainly show high quality care for patients and encourage other Turkish clinics too, says Oncotech CEO, Ilker Catan.

For additional information:
Tomas Gustafsson, CEO, Micropos Medical AB (publ), +46-31-772 80 99

About Micropos Medical AB (publ):
Micropos Medical AB (publ) (www.micropos.se) is a Swedish company that has developed the RayPilot® system, which is an electromagnetic positioning and real time tracking system for a fast and objective set-up and for continuous positioning during radiotherapy. A precise and safe localization of the tumor can dramatically improve the outcome of the treatment, particularly for hypofractionated protocols. The RayPilot® system consists mainly of three parts; one transmitter that is placed close by the tumor, a receiving system that is placed directly on the treatment couchtop and software that continuously shows the precise target location, and hence where to focus the linac beam. RayPilot® has a unique gating solution qualified and compatible for use with Varian's Clinac® iX linear accelerators and Trilogy® systems. Micropos will during 2016 release an upcoming RayPilot® transmitter for positioning, in-situ dosimetry and automatic patient identification. RayPilot® is CE certified for prostate and surface use. Follow us on Facebook, www.facebook.com/MicroposMedical. The Micropos share is traded under the stock ticker MPOS.

About Gayrettepe Florence Nightingale Hospital
Gayrettepe Florence Nightingale Hospital came into operation in 1997 as the Group Florence Nightingale's third hospital established under the aegis of the Turkish Cardiology Foundation. With its specialized personnel and unique technological facilities, this health care institution has achieved a world-wide reputation among the top health care institutions according to reports published by international research institutions.

Gayrettepe Florence Nightingale Hospital adopts the principle of offering the best health care services with the support of the state-of-the-art technology - all backed by the reliable background of Group Florence Nightingale experience. We aim to provide comprehensive health solutions to our international patients in maximum comfort.

You Must Be Logged In To Post A Comment